| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return | vs S&P 500 ⓘ |
|---|---|---|---|---|---|---|
|
FR:OR
L'Oreal
|
Jun 25, 2026 | BUY |
Buy
-0.1% avg upside
25 analysts
|
$435.00
12.34% Upside
|
+1.6% | · |
|
GB:RKT
Reckitt
|
Apr 23, 2026 | BUY |
Strong Buy
+557.9% avg upside
21 analysts
|
$6200.00
17.58% Upside
|
+11.0% | · |
|
CH:BARN
Barry Callebaut AG
|
Apr 17, 2026 | HOLD |
Hold
+37.8% avg upside
12 analysts
|
$1175.00
6.84% Upside
|
+3.6% | · |
|
DE:BEI
Beiersdorf
|
Mar 31, 2026 | BUY |
Hold
+15.3% avg upside
24 analysts
|
$95.00
21.85% Upside
|
+7.6% | · |
|
CH:NESN
Nestlé SA
|
Mar 25, 2026 | HOLD |
Buy
+21.7% avg upside
29 analysts
|
$85.00
5.46% Upside
|
+12.5% | · |
|
GB:HLN
Haleon PLC
|
Jan 26, 2026 | BUY |
Strong Buy
+22.9% avg upside
20 analysts
|
$455.00
27.10% Upside
|
-2.3% | · |
|
FR:BN
DANONE SA
|
Oct 29, 2025 | HOLD |
Buy
+7.1% avg upside
23 analysts
|
$77.00
13.29% Upside
|
-8.5% | · |
|
CH:GALD
Galderma Group AG
|
Oct 24, 2025 | BUY |
Strong Buy
+6.2% avg upside
10 analysts
|
$165.00
5.71% Downside
|
+29.6% | · |
|
GB:TATE
Tate & Lyle
|
Oct 02, 2025 | BUY |
Strong Buy
+5.7% avg upside
10 analysts
|
$540.00
2.19% Downside
|
+52.0% | · |
|
DE:HEN3
Henkel AG & Co. KGaA
|
May 09, 2025 | HOLD |
Hold
+2.4% avg upside
21 analysts
|
$75.00
1.95% Downside
|
-5.4% | · |
|
GB:ULVR
Unilever
|
Mar 28, 2025 | BUY |
Buy
+233.0% avg upside
26 analysts
|
$5850.00
23.16% Upside
|
-8.6% | · |
|
DE:HEN
Henkel AG & Co. KGaA
|
Mar 21, 2025 | HOLD |
Hold
+10.1% avg upside
14 analysts
|
$82.00
14.99% Upside
|
-4.0% | · |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.